Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-02-02

FDA Approved: NEXESTA FE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved NEXESTA FE, a generic fixed-dose combination oral contraceptive containing norethindrone, ethinyl estradiol, and ferrous fumarate. This action was …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEXESTA FE (NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE)

Snippet

ORIG AP for NEXESTA FE (NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE)